JPH08512319A - ジフルオロスタトン類似体 - Google Patents
ジフルオロスタトン類似体Info
- Publication number
- JPH08512319A JPH08512319A JP7504027A JP50402795A JPH08512319A JP H08512319 A JPH08512319 A JP H08512319A JP 7504027 A JP7504027 A JP 7504027A JP 50402795 A JP50402795 A JP 50402795A JP H08512319 A JPH08512319 A JP H08512319A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- amino
- benzyloxy
- difluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式 〔式中P1はQ又はBであり、ここでBは であり、ここでTは[(O)b-W-R]で、T’は[(O)b,-W'-R']又はHであり、ここで WとW’の各々は独立にC1-6アルキレン又は何も存在しないことを表し、RとR ’は各々独立に-CH2CHO、ヒドロキシC1-6アルキル、C1-6アルコキシC1-6アルキ ル、C1-6アルキル、Q、 又はR7であるが、但しWがR中の窒素原子に直接に結合される時は、WはC2-6ア ルキレンであることを条件とし、またW’がR’中の窒素原子に直接に結合され る時は、W’はC2-6アルキレンであることを条件とし、R又はR’が各々独立に アリールの時には、W又はW’は各々独立にC1-6アルキレンであることを条件と し、またBがp-ヒドロキシベンジル又はp-アルコキシベンジル以外である ことを条件としており、 P2は、C1-6アルキル、シクロペンチル、ヒドロキシC1-6アルキル、フェニ ル、ベンジル、又は3-テトラヒドロフリルであり、 R1は、ベンジルオキン、C1-6アルコキシ、C1-6アルキル、フェニル、ベン ジル、フェネチル、フルオレニルメチレノキシ、2-イソキノリニル、PDL、 N(R4)(ベンジル)、及びN(R4)(PDL)、(ただしPDLは-(CH2)a-2-、3-又は4-ピリジ ルである)又はp-置換ベンジロキシ(但しその置換はニトロ、OH、アミノ、C1- 6 アルコキシ、ヒドロキシC1-6アルキレン、又はハロゲノによる)であり、 R3は、C1-6アルケニル、C1-6アルコキシ、ヒドロキシC1-6アルキル、C1- 6 アルキル、又はOHであり、 R4は、H、C1-6アルキル、フェニル、又はベンジルであり、 R5は、C7-15アルキル、C7-15アルコキシ、 CH([(CH2)d-O-CH2]X-R8)2 、 又はCH(V)(Z)であり、ここでYはC1-15アルキル、ヒドロキシC1-15アルキル 、又は Zは(CH2)d-O-CHO、 C1-6アルキレン-O-(CH2)d-(O-CH2-CH2)e-O-C1-6アルキル、 又は(CH2)d−O-(CH2)d,R7であるが、但しR7がピペラジニル、置換ピペラジ ニル、ビペリジル、又はモルホリニルの時にはd’= 2であることを条件とし、 VはOR4又はヒドロキシC1-6アルキルである。 R6はH又はC1-3アルキルであり、 R7はピペラジニル、置換ピペラジニル、ピペリジル、モルホリニル、ピリジル 、ピラジニル、ピリミジニル、又はフェニルであり、ここで置換ピペラジニルは その1個の窒素原子上でCHO、C(O)NHR4、C1-C4アルキル、又はCO2R4 で置換されたピペラジニルであり、 R8はピリミジル、ピリジル、ピラジニル、又はフェニルであり、 aはゼロ、1、2、又は3; bとb’は各々独立に、ゼロ又は1; dとd’は各々独立に、1又は2; eとe’は各々独立に、ゼロ、1又は2であり;またxはゼロ又は1である。 〕の化合物、その立体異性体類、ハイドレート類、イソスター類及び製薬上受け 入れられる塩。 2.xが1である請求項1に記載の化合物。 3.P1がBである請求項1に記載の化合物。 4.P2がC1-6アルキルである請求項1に記載の化合物。 5.R5がCH(Y)(Z)である請求項1に記載の化合物。 6. N-[4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-1,3- ジオキソ-5-(4-ベンジロキシ)フェニル-ペンチル]-O-[(3-ピリジル)メチル]-D- バリノール、 4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-3-オキソ-5- (4-ベンジロキシ)フェニル-N(1-イソプロピル-2-メチル-プロパン)ペンタンアミ ド、 4-[N-(3-ピリジルプロピオニル)-L-バリル]アミノ-2,2-ジフルオロ-3-オキソ- 5-(4-ベンジロキシ)フェニル-N(1-イソプロピル-2-メチル-プロパン)ペンタンア ミド、 N-[4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ−1,3-ジ オキソ-5-(4-ベンジロキシ)フェニル-ペンチル]-ジ(O-ベンジル)セリノール、 4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2- ジフルオロ-3-オキソ-5-(4-ベンジロキシ)フェニル-N(α-L-メチル)ベンジルペ ンタンアミド、 N-[4-(N-ベシジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-1,3-ジオ キソ-5-(4-ベンジロキシ)フェニル-ペンチル]-O-(2-メトキシエトキシメチル)-D -バリノール、 N-[4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-1,3-ジオ キソ-5-(4-ベンジロキシ)フェニル-ペンチル]-O-ホルミル-D-バリノール、 N-[4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-1,3-ジオ キソ-5-(4-ベンジロキシ)フェニル-ペンチル]-O-[2-(2-メトキシエトキシ)-1-エ チル]-D-バリノール、 4-(N-ベシジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-3-オキソ-5- (4-ベンジロキシ)フェニル-N-ビンズヒドリル-ペンタンアミド、 4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-3-オキソ-5- (4-ベンジロキシ)フェニル-N[1,1-ジ(2-ピリジル)メチル]ペンタンアミド、 N-[4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2,2-ジフルオロ-1,3-ジオ キソ-5-(4-{2-N-モルホリル}エチルオキシ)フェニル-ペンチル]-O-[(3-ピリジル )メチル]-D-バリノール、又は N-[4-(N-ベンジロキシカルボニル-L-バリル)アミノ-2, 2-ジフルオロ-1,3-ジオキソ-5-(4-{2-N-モルホリル}エチルオキシ)フェニル-ペ ンチル]-O-[(2-ピリジル)メチル]-D-バリノールである、請求項1に記載の化合 物。 7.製薬活性化合物として使用する請求項1に記載の化合物。 8.HIV感染処置の為に使用する請求項1に記載の化合物。 9.製薬上受入れられる担体と組合わせる場合もある請求項1に記載の化合物を 含む製剤組成物。 10.HIV感染処置の為の請求項7記載の製剤組成物。 11.製薬上受入れられる担体と組合わせる場合もある、HIV感染処置の為の 製剤組成物を製造する請求項1に記載の化合物の用途。 12. 式 〔式中P1はQ又はBであり、ここでBは であり、ここでTは[(O)b-W-R]で、T’は[(O)b,-W'-R']又はHであり、ここで Wと、W’の各々は独立にC1-6アル キレシ又は何も存在しないことを表し、RとR’は各々独立に-CH2CHO、ヒドロ キシC1-6アルキル、C1-6アルコキシC1-6アルキル、C1-6アルキル、Q、 又はR7であるが、但しWがR中の窒素原子に直接に結合される時は、WはC2-6ア ルキレンであることを条件とし、またW'がR'中の窒素原子に直接に結合される 時は、W'はC2-6アルキレンであることを条件とし、R又はR'が各々独立にアリ ールの時には、W又はW'は各々独立にC1-6アルキレンであることを条件とし、 またBがp-ヒドロキシベンジル又はp-アルコキシベンジル以外であることを条件 としており、 P2は、C1-6アルキル、シクロペンチル、ヒドロキシC1-6アルキル、フェニ ル、ベンジル、又は3-テトラヒドロフリルであり、 R1は、ベンジルオキシ、C1-6アルコキシ、C1-6アルキル、フェニル、ベン ジル、フェネチル、フルオレニルメチレノキシ、2-イソキノリニル、PDL、 N(R4)(ベンジル)、及びN(R4)(PDL)、(但しPDLは-(CH2)a-2-、3-又は4-ピリジル である)又はp-置換ベンジロキシ(但しその置換はニトロ、OH、アミノ、C1-6 アルコキシ、ヒドロキシC1-6アルキレン、又はハロゲノによる)であり、 R3は、C1-6アルケニル、C1-6アルコキシ、ヒドロキシC1-6アルキル、C1- 6 アルキル、又はOHであり、 R4は、H、C1-6アルキル、フェニル、又はベンジルであり、 R5は、C7-15アルキル、C7-15アルコキシ、CH([(CH2)d-O-CH2]x-R8)2 、 又はCH(Y)(Z)であり、ここでYはC1-15アルキル、ヒドロキシC1-15アルキル 、又は Zは(CH2)d-O-CHO、C1-6アルキレン-O-(CH2)d-(O-CH2-CH2)e- O-C1-6アルキル、 又は(CH2)d-O-(CH2)d'R7であるが、但しR7がピペラジニル、置換ピペラジ ニル、ピペリジル、又はモルホ リニルの時にはd'=2であることを条件とし、 VはOR4又はヒドロキシC1-6アルキルであり、 R6はH又はC1-3アルキルであり、 R7はピペラジニル、置換ピペラジニル、ピペリジル、モルホリニル、ピリジル 、ピラジニル、ピリミジニル、又はフェニルであり、ここで置換ピペラジニルは その1個の窒素原子上でCHO、C(O)NHR4、C1-C4アルキル、又はCO2R4 で置換されたピペラジニルであり、 R8はピリミジル、ピリジル、ピラジニル、又はフェニルであり、 aはゼロ、1、2、又は3; bとb’は各々独立に、ゼロ又は1; dとd’は各々独立に、1又は2; eとe’は各々独立に、ゼロ、1又は2であり;またxはゼロ又は1である。〕 の化合物、そのハイドレート類、イソスター類及び製薬上受け入れられる塩を製 造する方法であって、式 〔式中、R1、P2、P1、R5、及びR6は上に定義の通りである〕の化合物を使 用し、その化合物を酸化し、必要ならば生じた酸化された化合物をその製薬上受 入れられる塩に変換することからなる方法。 13. 酸化段階がデス マーチン酸化を使用する、請求項12に記載の方法。 14. 酸化段階がスウェルン酸化を使用する、請求項12に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93401785 | 1993-07-08 | ||
EP93401785.6 | 1993-07-08 | ||
PCT/US1994/006376 WO1995001958A1 (en) | 1993-07-08 | 1994-06-07 | Difluoro statone analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08512319A true JPH08512319A (ja) | 1996-12-24 |
Family
ID=8214732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7504027A Pending JPH08512319A (ja) | 1993-07-08 | 1994-06-07 | ジフルオロスタトン類似体 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5717093A (ja) |
EP (1) | EP0707564B1 (ja) |
JP (1) | JPH08512319A (ja) |
KR (1) | KR100316864B1 (ja) |
CN (1) | CN1126988A (ja) |
AT (1) | ATE196465T1 (ja) |
AU (1) | AU680009B2 (ja) |
CA (1) | CA2166693C (ja) |
DE (1) | DE69425971T2 (ja) |
ES (1) | ES2152982T3 (ja) |
FI (1) | FI120389B (ja) |
HU (1) | HUT73411A (ja) |
IL (1) | IL110227A0 (ja) |
NO (1) | NO306343B1 (ja) |
NZ (1) | NZ268202A (ja) |
TW (1) | TW288005B (ja) |
WO (1) | WO1995001958A1 (ja) |
ZA (1) | ZA944818B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09502437A (ja) * | 1993-09-09 | 1997-03-11 | メレルファーマスーティカルズ インコーポレイテッド | ジフルオロスタトン抗ウイルス類似体 |
TW200910648A (en) | 2007-08-31 | 2009-03-01 | Isotech Products Inc | Forming process of resin lens of an LED component |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH672792A5 (ja) * | 1985-02-19 | 1989-12-29 | Sandoz Ag | |
US5066643A (en) * | 1985-02-19 | 1991-11-19 | Sandoz Ltd. | Fluorine and chlorine statine or statone containing peptides and method of use |
EP0218688B1 (en) | 1985-04-19 | 1990-09-12 | The Upjohn Company | Dihalo-statine substituted renin inhibitors |
GB8619182D0 (en) * | 1986-08-06 | 1986-09-17 | Sandoz Ltd | Peptides & derivatives |
NZ223148A (en) * | 1987-01-16 | 1989-10-27 | Merrell Dow Pharma | Peptide derivatives having peptidase inhibition activity |
FR2614533A1 (fr) * | 1987-04-23 | 1988-11-04 | Sandoz Sa | Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments |
GB2212158A (en) * | 1987-12-15 | 1989-07-19 | Sandoz Ltd | Trialkylsilymethyl-substituted peptides; renin inhibitors |
HUT58764A (en) * | 1988-07-08 | 1992-03-30 | Smithkline Beckman Corp | Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates |
IL90872A0 (en) | 1988-07-08 | 1990-02-09 | Smithkline Beckman Corp | Retroviral protease binding peptides |
CA2010531A1 (en) * | 1989-03-06 | 1990-09-06 | Werner Neidhart | Amino acid derivatives |
US5151438A (en) * | 1989-05-23 | 1992-09-29 | Abbott Laboratories | Retroviral protease inhibiting compounds |
NZ241099A (en) * | 1991-01-02 | 1994-08-26 | Merrell Dow Pharma | Difluorostatone analogues and derivatives and pharmaceutical compositions |
CZ229594A3 (en) * | 1992-03-25 | 1995-04-12 | Pfizer | Peptides, process of their preparation, their use and pharmaceutical compositions based thereon |
GB9210744D0 (en) * | 1992-05-20 | 1992-07-08 | Pfizer Ltd | Antiviral peptides |
ATE199545T1 (de) * | 1992-05-21 | 2001-03-15 | Monsanto Co | Inhibitoren retroviraler proteasen |
NZ288836A (en) * | 1994-07-15 | 1998-01-26 | Merrell Pharma Inc | Difluorostatone derivatives; used as antiviral agents |
JP2015518386A (ja) | 2013-02-08 | 2015-07-02 | テイト タワーズ マニュファクチャリング、 エルエルシー | 視覚的に透明な可撓性支持部材を有する飛行プラットフォーム |
-
1994
- 1994-06-07 AU AU71008/94A patent/AU680009B2/en not_active Ceased
- 1994-06-07 US US08/578,698 patent/US5717093A/en not_active Expired - Lifetime
- 1994-06-07 HU HU9503706A patent/HUT73411A/hu unknown
- 1994-06-07 DE DE69425971T patent/DE69425971T2/de not_active Expired - Lifetime
- 1994-06-07 ES ES94920095T patent/ES2152982T3/es not_active Expired - Lifetime
- 1994-06-07 CA CA002166693A patent/CA2166693C/en not_active Expired - Fee Related
- 1994-06-07 KR KR1019960700062A patent/KR100316864B1/ko not_active IP Right Cessation
- 1994-06-07 NZ NZ268202A patent/NZ268202A/en unknown
- 1994-06-07 WO PCT/US1994/006376 patent/WO1995001958A1/en active IP Right Grant
- 1994-06-07 AT AT94920095T patent/ATE196465T1/de not_active IP Right Cessation
- 1994-06-07 JP JP7504027A patent/JPH08512319A/ja active Pending
- 1994-06-07 CN CN94192700A patent/CN1126988A/zh active Pending
- 1994-06-07 EP EP94920095A patent/EP0707564B1/en not_active Expired - Lifetime
- 1994-07-04 ZA ZA944818A patent/ZA944818B/xx unknown
- 1994-07-05 TW TW083106128A patent/TW288005B/zh active
- 1994-07-06 IL IL11022794A patent/IL110227A0/xx unknown
-
1996
- 1996-01-05 NO NO960048A patent/NO306343B1/no not_active IP Right Cessation
- 1996-01-05 FI FI960051A patent/FI120389B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100316864B1 (ko) | 2002-11-13 |
HU9503706D0 (en) | 1996-02-28 |
NZ268202A (en) | 1997-09-22 |
EP0707564A1 (en) | 1996-04-24 |
DE69425971D1 (de) | 2000-10-26 |
ES2152982T3 (es) | 2001-02-16 |
AU7100894A (en) | 1995-02-06 |
US5717093A (en) | 1998-02-10 |
FI960051A0 (fi) | 1996-01-05 |
FI120389B (fi) | 2009-10-15 |
HUT73411A (en) | 1996-07-29 |
CA2166693A1 (en) | 1995-01-09 |
NO960048L (no) | 1996-03-05 |
IL110227A0 (en) | 1994-10-21 |
TW288005B (ja) | 1996-10-11 |
AU680009B2 (en) | 1997-07-17 |
NO306343B1 (no) | 1999-10-25 |
FI960051A (fi) | 1996-03-07 |
EP0707564B1 (en) | 2000-09-20 |
WO1995001958A1 (en) | 1995-01-19 |
KR960703844A (ko) | 1996-08-31 |
NO960048D0 (no) | 1996-01-05 |
ATE196465T1 (de) | 2000-10-15 |
ZA944818B (en) | 1995-02-22 |
CA2166693C (en) | 1999-08-24 |
DE69425971T2 (de) | 2001-05-23 |
CN1126988A (zh) | 1996-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4091653B2 (ja) | レトロウイルスプロテアーゼ阻害剤として有用なn−(アルカノイルアミノ−2−ヒドロキシプロピル)スルホンアミド | |
JP3198416B2 (ja) | 抗ウイルス化合物類 | |
CA2195125C (en) | Difluorostatone antiviral agents | |
JPH08512319A (ja) | ジフルオロスタトン類似体 | |
CA2170607C (en) | Difluoro statone antiviral analogs | |
US5559140A (en) | Difluoro statone analogs | |
US6114380A (en) | Difluoro statone analogs | |
CA2249786C (en) | Difluoro statone analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040406 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040706 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040823 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041001 |
|
RD12 | Notification of acceptance of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7432 Effective date: 20050401 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060516 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20060502 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060711 |